Related references
Note: Only part of the references are listed.Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma
Arnaud Bourdin et al.
JOURNAL OF ASTHMA (2021)
Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline
Fernando Holguin et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease
Dave Singh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019
Dave Singh et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome
F. L. Kuang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Benralizumab for the Prevention of COPD Exacerbations
G. J. Criner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Targeting IL-5 in COPD
Dharani K. Narendra et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2019)
Decreased Human Adipose Tissue-Resident Eosinophils in Obese Subjects Is Associated with Increased Insulin Resistance
James D. Hernandez et al.
DIABETES (2019)
BENRALIZUMAB TREATMENT IS NOT ASSOCIATED WITH ORAL CORTICOSTEROID-LIKE INCREASES IN WEIGHT AND BLOOD PRESSURE
J. Kreindler et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)
Disseminated herpes zoster following treatment with benralizumab
Ajay Kumar Mishra et al.
CLINICAL RESPIRATORY JOURNAL (2019)
Inhaled corticosteroids and risk of upper respiratory tract infection in patients with asthma: a meta-analysis
Mingjin Yang et al.
INFECTION (2019)
Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma
Sumita Khatri et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
A systematic review of the adverse events and economic impact associated with oral corticosteroids in asthma
Khalid Al Efraij et al.
JOURNAL OF ASTHMA (2019)
Activated Eosinophils Exert Antitumorigenic Activities in Colorectal Cancer
Hadar Reichman et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
William W. Busse et al.
LANCET RESPIRATORY MEDICINE (2019)
Intravital imaging allows real-time characterization of tissue resident eosinophils
Andrew Chojnacki et al.
COMMUNICATIONS BIOLOGY (2019)
Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis
Charlene M. Prazma et al.
RESPIRATORY RESEARCH (2019)
Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma
J. Mark FitzGerald et al.
JOURNAL OF ASTHMA AND ALLERGY (2019)
Eosinophils: The unsung heroes in cancer?
Gilda Varricchi et al.
ONCOIMMUNOLOGY (2018)
Mepolizumab use Post-approval academic practice experience
Mariel R. Benjamin et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Eosinophils from Physiology to Disease: A Comprehensive Review
Giuseppe A. Ramirez et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Targeting the Interleukin-5 Pathway for Treatment of Eosinophilic Conditions Other than Asthma
Florence Roufosse
FRONTIERS IN MEDICINE (2018)
Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial
Pamela L. Zeitlin et al.
JOURNAL OF ASTHMA AND ALLERGY (2018)
Changes in eosinophil count during bacterial infection: revisiting an old marker to assess the efficacy of antimicrobial therapy
B. Davido et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus
Amali E. Samarasinghe et al.
JOURNAL OF IMMUNOLOGY (2017)
Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma
Parameswaran Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab
Corrado Pelaia et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Long-term Safety and Efficacy of Reslizumab in Patients with Eosinophilic Asthma
Kevin Murphy et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)
Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review
J. Bradford Rice et al.
CLINICAL THERAPEUTICS (2017)
Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma
Diego Bagnasco et al.
FRONTIERS IN MEDICINE (2017)
Eosinophil Activation Status in Separate Compartments and Association with Asthma
Mats W. Johansson
FRONTIERS IN MEDICINE (2017)
Homeostatic Eosinophils: Characteristics and Functions
Thomas Marichal et al.
FRONTIERS IN MEDICINE (2017)
Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions
Simon Couillard et al.
CHEST (2017)
The Eosinophil in Infection
Karen A. Ravin et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2016)
Targeting Inflammation in Cancer Prevention and Therapy
Jelena Todoric et al.
CANCER PREVENTION RESEARCH (2016)
Eosinophils in Cancer: Favourable or Unfavourable?
Samy Sakkal et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Lung-resident eosinophils represent a distinct regulatory eosinophil subset
Claire Mesnil et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
Eugene R. Bleecker et al.
LANCET (2016)
Benralizumab, an anti-interleukin-5 receptor a monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
J. Mark FitzGerald et al.
LANCET (2016)
Reductions in eosinophil biomarkers by benralizumab in patients with asthma
Tuyet-Hang Pham et al.
RESPIRATORY MEDICINE (2016)
Eosinophils in Helminth Infection: Defenders and Dupes
Lu Huang et al.
TRENDS IN PARASITOLOGY (2016)
Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies
Hector G. Ortega et al.
LANCET RESPIRATORY MEDICINE (2016)
Historical cohort study examining comparative effectiveness of albuterol inhalers with and without integrated dose counter for patients with asthma or chronic obstructive pulmonary disease
David B. Price et al.
JOURNAL OF ASTHMA AND ALLERGY (2016)
Emerging Roles for Eosinophils in the Tumor Microenvironment
Hadar Reichman et al.
TRENDS IN CANCER (2016)
The infiltration and functional regulation of eosinophils induced by TSLP promote the proliferation of cervical cancer cell
Feng Xie et al.
CANCER LETTERS (2015)
Interleukin-5 Facilitates Lung Metastasis by Modulating the Immune Microenvironment
R. Zaynagetdinov et al.
CANCER RESEARCH (2015)
Inflammation Fuels Tumor Progress and Metastasis
Jingyi Liu et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
IL-1β in eosinophil-mediated small intestinal homeostasis and IgA production
Y. Jung et al.
MUCOSAL IMMUNOLOGY (2015)
Sputum eosinophilia is a determinant of FEV1 decline in occupational asthma: results of an observational study
Donatella Talini et al.
BMJ OPEN (2015)
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
Mario Castro et al.
LANCET RESPIRATORY MEDICINE (2015)
Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study
David B. Price et al.
LANCET RESPIRATORY MEDICINE (2015)
The Global Burden of Cancer 2013 Global Burden of Disease Cancer Collaboration
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2015)
Activated mouse eosinophils protect against lethal respiratory virus infection
Caroline M. Percopo et al.
BLOOD (2014)
Eosinophils and Type 2 Cytokine Signaling in Macrophages Orchestrate Development of Functional Beige Fat
Yifu Qiu et al.
CELL (2014)
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Kian Fan Chung et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Importance of concomitant local and systemic eosinophilia in uncontrolled asthma
Florence Nicole Schleich et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Eosinophilic inflammation in COPD: prevalence and clinical characteristics
Dave Singh et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Eosinophils Promote Generation and Maintenance of Immunoglobulin-A-Expressing Plasma Cells and Contribute to Gut Immune Homeostasis
Van Trung Chu et al.
IMMUNITY (2014)
Asthma and infections: Is the risk more profound than previously thought?
William W. Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Risks for infection in patients with asthma (or other atopic conditions): Is asthma more than a chronic airway disease?
Young J. Juhn
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab
Aidan Long et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
A Transient Increase in Eosinophils Is Associated with Prolonged Survival in Men with Metastatic Castration-Resistant Prostate Cancer Who Receive Sipuleucel-T
Douglas G. McNeel et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Anti-IL5 therapy for asthma and beyond
Manali Mukherjee et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2014)
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
Michel Laviolette et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Increased Risk of Herpes Zoster in Children with Asthma: A Population-Based Case-Control Study
Bong-Seong Kim et al.
JOURNAL OF PEDIATRICS (2013)
Induction of Malignant Plasma Cell Proliferation by Eosinophils
Tina W. Wong et al.
PLOS ONE (2013)
Increased risk of pertussis in patients with asthma
Conrad R. Capili et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Identification of Innate IL-5-Producing Cells and Their Role in Lung Eosinophil Regulation and Antitumor Immunity
Masashi Ikutani et al.
JOURNAL OF IMMUNOLOGY (2012)
Streptococcus pyogenes upper respiratory infection and atopic conditions other than asthma: a retrospective cohort study
Young J. Juhn et al.
PRIMARY CARE RESPIRATORY JOURNAL (2012)
Interleukin-5 and IL-5 receptor in health and diseases
Kiyoshi Takatsu
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2011)
Host-derived Interleukin-5 Promotes Adenocarcinoma-induced Malignant Pleural Effusion
Georgios T. Stathopoulos et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Eosinophils in health and disease: the LIAR hypothesis
J. J. Lee et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2010)
Eosinophils as antigen-presenting cells in allergic upper airway disease
Praveen Akuthota et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2010)
MEDI-563, a humanized anti-IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function
Roland Kolbeck et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Eosinopenia: Is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital?
Hamid Shaaban et al.
JOURNAL OF CRITICAL CARE (2010)
Filarial Parasites Develop Faster and Reproduce Earlier in Response to Host Immune Effectors That Determine Filarial Life Expectancy
Simon A. Babayan et al.
PLOS BIOLOGY (2010)
Allergic inflammation does not impact chemical-induced carcinogenesis in the lungs of mice
Konstantinos Doris et al.
RESPIRATORY RESEARCH (2010)
Eosinophil Deficiency Compromises Parasite Survival in Chronic Nematode Infection
Valeria Fabre et al.
JOURNAL OF IMMUNOLOGY (2009)
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Pranabashis Haldar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus
Simon Phipps et al.
BLOOD (2007)
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial
R. Siva et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Regulation of carcinogenesis by IL-5 and CCL11: A potential role for eosinophils in tumor immune surveillance
Ljubov Simson et al.
JOURNAL OF IMMUNOLOGY (2007)
Retrospective analysis of the prognostic role of tissue eosinophil and mast cells in Hodgkin's lymphoma
Katalin Keresztes et al.
PATHOLOGY & ONCOLOGY RESEARCH (2007)
Eosinophils can function as antigen-presenting cells to induce primary and secondary immune responses to Strongyloides stercoralis
Udaikumar M. Padigel et al.
INFECTION AND IMMUNITY (2006)
Cancer incidence in a general population of asthma patients
A González-Pérez et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2006)
Cancer mortality among US men and women with asthma and hay fever
MC Turner et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Human eosinophils selectively recognize and become activated by bacteria belonging to different taxonomic groups
L Svensson et al.
MICROBES AND INFECTION (2005)
A critical role for eosinophils in allergic airways remodeling
AA Humbles et al.
SCIENCE (2004)
Defining a link with asthma in mice congenitally deficient in eosinophils
JJ Lee et al.
SCIENCE (2004)
Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: An eotaxin and STAT6-dependent process
J Mattes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway
PT Flood-Page et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial
RH Green et al.
LANCET (2002)
Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo
CN Yu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Lung cancer risk in a population-based cohort of patients hospitalized for asthma in Sweden
P Boffetta et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Significance of epidermal growth factor receptor and tumor associated tissue eosinophilia in the prognosis of patients with nasopharyngeal carcinoma
M Fujii et al.
AURIS NASUS LARYNX (2002)
Share Paper
